Related references
Note: Only part of the references are listed.Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba
Yasser Bustanji et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2011)
Berberine: a potential phytochemical with multispectrum therapeutic activities
Parameswara Rao Vuddanda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Yueshan Hu et al.
FITOTERAPIA (2010)
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
Woo Sik Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Obesity: Pathophysiology and Clinical Management
Tatiana Gurevich-Panigrahi et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Strategies and tactics for optimizing the Hit-to-Lead process and beyond - A computational chemistry perspective
Charles J. Manly et al.
DRUG DISCOVERY TODAY (2008)
Pancreatic lipase inhibitors from natural sources: unexplored potential
Rahul B. Birari et al.
DRUG DISCOVERY TODAY (2007)
Emerging therapeutic strategies for obesity
Karen E. Foster-Schubert et al.
ENDOCRINE REVIEWS (2006)
The obesity pipeline: current strategies in the development of anti-obesity drugs
Dunstan Cooke et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Berberine potently inhibits protein tyrosine phosphatase 1B: Investigation by docking simulation and experimental validation
Yasser Bustanji et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2006)
Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity
YG Shi et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Addressing the unmet medical need for safe and effective weight loss therapies
CM Arbeeny
OBESITY RESEARCH (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Human digestive and metabolic lipases - a brief review
M Mukherjee
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC (2003)
Molecular pathways to obesity
K Hofbauer
INTERNATIONAL JOURNAL OF OBESITY (2002)
Orlistat: its current status as an anti-obesity drug
A Ballinger et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Obesity, the metabolic syndrome, and cardiovascular disease
GL Vega
AMERICAN HEART JOURNAL (2001)
Share Paper
